Safety, Tolerability, and Pharmacokinetics of Multiple Repeated Oral Doses of the α2/3/5‐Subtype Selective GABA A ‐Positive Allosteric Modulator PF‐06372865 in Healthy Volunteers-Reference-Cited by-同舟云学术

Safety, Tolerability, and Pharmacokinetics of Multiple Repeated Oral Doses of the α2/3/5‐Subtype Selective GABA A ‐Positive Allosteric Modulator PF‐06372865 in Healthy Volunteers

Published:2021-01-19 Issue: Volume: Page:
ISSN:2160-763X
Container-title:Clinical Pharmacology in Drug Development
language:en
Short-container-title:Clinical Pharmacology in Drug Development

Author:

Gurrell Rachel¹,Whitlock Mark²,Wei Hua³,Shen Zhongzhou⁴,Ogden Adam⁵

Affiliation:

1. Cerevel Therapeutics LLC Boston Massachusetts USA

2. Pfizer Inc. Granta Park Cambridge UK

3. Pfizer Inc. Shanghai China

4. Pfizer Inc. San Diego California USA

5. Pfizer Inc. Groton Connecticut USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmaceutical Science

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpdd.912

Reference25 articles.

1. Which GABAA‐receptor subtypes really occur in the brain?;McKernan RM;Trends Neurosci.,1996

2. Benzodiazepine actions mediated by specific γ‐aminobutyric acid A receptor subtypes;Rudolph Y;Nature.,1999

3. Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype;McKernan RM;Nature Neurosci.,2000

4. Differential contribution of GABAA receptor subtypes to the anticonvulsant efficacy of benzodiazepine site ligands;Fradley RL;J Psychopharmacol.,2007

5. Reversal of pathological pain through specific spinal GABAA receptor subtypes;Knabl J;Nature.,2008

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GABA System in Anxiety Disorders: A Review of Current and Novel GABAergic Drugs;Journal of Education, Humanities and Social Sciences;2023-11-26

2. New GABA-Targeting Therapies for the Treatment of Seizures and Epilepsy: II. Treatments in Clinical Development;CNS Drugs;2023-08-21

3. Advances in Epilepsy: Mechanisms, Clinical Trials, and Drug Therapies;Journal of Medicinal Chemistry;2023-04-04

4. Pronounced antiseizure activity of the subtype‐selective GABA _A positive allosteric modulator darigabat in a mouse model of drug‐resistant focal epilepsy;CNS Neuroscience & Therapeutics;2022-08-14

5. Can GABAkines quiet the noise? The GABAA receptor neurobiology and pharmacology of tinnitus;Biochemical Pharmacology;2022-07